Search This Blog

Thursday, February 21, 2019

Halozyme reports Q4 EPS (1c), consensus (3)

Reports Q4 revenue $60.2M, consensus $59.77M. Cash, cash equivalents and marketable securities were $354.5M at December 31, 2018, compared to $469.2M at December 31, 2017.
https://thefly.com/landingPageNews.php?id=2868093

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.